Jan 12, 2022 / 01:15PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst
Good morning, and thanks for joining the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm. And our next presenting company is Autolus. And here to talk to us a little bit about the company is CEO, Christian Itin. There is a Q&A session after the presentation. So just click the icon and I'll work in questions where appropriate. With that, Christian, thanks so much for sharing some of your time with us this week.
Christian Martin Itin - Autolus Therapeutics plc - CEO & Director
Well, thank you very much. Thanks, Eric, for having us at the conference. I'm looking forward to giving you an update on where we are with Autolus and give you an outlook on the activities planned for this year and into next year.
So we're a company focused on the development of CAR T therapies. We're listed on NASDAQ. If you go on Slide 2, please have a look at our SEC filings for a full set of disclosures and also the risk factors.
Autolus Therapeutics PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers